Pharmaceutical Preparations · DE · CIK 1390478
Develops novel cancer therapeutics, including peptide immunotherapy and CDK9 inhibitors
Comparable business profile · signals at a glance
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
In the 90 days to Nov 19, 2025: 1 insider bought $101K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 19, 2025 | Kalin Katherine BachDirector | Buy | 63,400 | $1.59 | $101K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.